Receptor Biologix

About:

Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases.

Website: http://www.receptorbiologix.com/

Top Investors: Oregon Health & Science University, Domain Associates, Essex Woodlands Healthcare Partners, Takeda Ventures, Skyline Ventures

Description:

Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases. The company is headquartered in Palo Alto, California.

Total Funding Amount:

$33.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2003-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2005-04-29

IPO Status:

Private

Industries: